1 hedge funds and family offices disclose a IVZ position in their latest SEC 13F filing — combined $6K in market value.
| # | Investor | Fund | Shares | Value | % of Portfolio | Filed |
|---|---|---|---|---|---|---|
| 1 | Olstein Capital Management | Olstein Capital Management LP | 233,000 | $6K | 1.26% | 2025-12-31 |
As of the latest 13F window, 1 tracked superinvestors hold IVZ. The largest disclosed position is Olstein Capital Management at $6K (1.3% of portfolio).
13F filings are due 45 days after each quarter end and capture long-equity positions held by U.S. institutional managers with $100M+ AUM. Use this page to see exactly who is buying IVZ, how concentrated each position is, and the implied conviction level relative to the rest of each investor's book.
Key takeaways
1 hedge funds and family offices disclose a IVZ position in their latest SEC 13F filing — combined $6K in market value.
| # | Investor | Fund | Shares | Value | % of Portfolio | Filed |
|---|---|---|---|---|---|---|
| 1 | Olstein Capital Management | Olstein Capital Management LP | 233,000 | $6K | 1.26% | 2025-12-31 |
As of the latest 13F window, 1 tracked superinvestors hold IVZ. The largest disclosed position is Olstein Capital Management at $6K (1.3% of portfolio).
13F filings are due 45 days after each quarter end and capture long-equity positions held by U.S. institutional managers with $100M+ AUM. Use this page to see exactly who is buying IVZ, how concentrated each position is, and the implied conviction level relative to the rest of each investor's book.
Key takeaways